Characterization of central nervous system multiple myeloma in the era of novel therapies

Leuk Lymphoma. 2016 Jul;57(7):1709-13. doi: 10.3109/10428194.2015.1122786. Epub 2016 Jan 4.

Authors

Nazanin Majd¹, Xiao Wei¹, Alexis Demopoulos^{2

3}, Adilia Hormigo^{2

3}, Ajai Chari^{1

2}

Affiliations

¹ a Department of Medicine , Mount Sinai Hospital , New York , NY , USA ;
² b Department of Hematology - Oncology , Mount Sinai Hospital , New York , NY , USA ;
³ c Department of Neurology , Mount Sinai Hospital , New York , NY , USA.

PMID: 26727654
DOI: 10.3109/10428194.2015.1122786

No abstract available

Publication types

Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Central Nervous System Neoplasms / diagnosis*
Central Nervous System Neoplasms / diagnostic imaging
Central Nervous System Neoplasms / therapy*
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Myeloma / diagnosis*
Multiple Myeloma / diagnostic imaging
Multiple Myeloma / therapy*
Radiotherapy / methods
Stem Cell Transplantation / methods
Survival Analysis
Transplantation, Autologous
Treatment Outcome